Phase 1b trial Mipasetamab Uzoptirine (ADCT-601-102) dose escalation in patients with advanced bone and soft tissue sarcomas

被引：0
|
作者：
Van Tine, Brian Andrew
Chen, Christopher T.
Moreno, Victor
Davis, Elizabeth J.
de Miguel, Maria J.
Italiano, Antoine
Saada-Bouzid, Esma
Milhem, Mohammed
Valverde, Claudia
Chawla, Sant P.
Naqash, Abdul Rafeh
Carter, Louise
Jones, Robin
Conti, Ilaria
Boni, Joe
Havenith, Karin
LeBruchec, Yvan
Pantano, Serafino
Blay, Jean-Yves
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-CT059
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT059
引用
收藏
页数：3
相关论文
共 50 条
  • [41] A phase 1B dose escalation trial of ISIS 14803, an antisense inhibitor of HCV, in patients with chronic HCV: Final report.
    McHutchison, JG
    Pockros, PJ
    Patel, K
    Nyberg, L
    Yu, RZ
    Kwoh, TJ
    Dorr, FA
    HEPATOLOGY, 2002, 36 (04) : 303A - 303A
  • [42] Phase II Trial of Cetuximab in Patients With Metastatic or Locally Advanced Soft Tissue or Bone Sarcoma
    Ha, Huan T.
    Griffith, Kent A.
    Zalupski, Mark M.
    Schuetze, Scott M.
    Thomas, Dafydd G.
    Lucas, David R.
    Baker, Laurence H.
    Chugh, Rashmi
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (01): : 77 - 82
  • [43] A PHASE 1/1B DOSE ESCALATION AND COHORT EXPANSION STUDY OF MGC018 IN COMBINATION WITH LORIGERLIMAB IN PATIENTS WITH ADVANCED SOLID TUMORS (AST)
    Powderly, John
    Kaminker, Patrick
    Zhao, Enxu
    Casey, Denise
    Shenderov, Eugene
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A789 - A789
  • [44] A phase 1B dose escalation study of ETC-159 in combination with pembrolizumab in advanced or metastatic solid tumours
    Tan, David Shao Peng
    Ng, Matthew C. H.
    Subbiah, Vivek
    Messersmith, Wells A.
    Strickler, John H.
    Diermayr, Veronica
    Cometa, Julienne
    Blanchard, Stephanie
    Nellore, Ranjani
    Pendharkar, Vishal
    Gan, Bong Hwa
    Rozaini, Nurul Nazihah
    Koh, Claudia
    Sarma, Suman
    Poh, Huay Mei
    Lezhava, Alexander
    Prativadibhayankaram, Venkateshan Srirangam
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] A PHASE 1/1B DOSE-ESCALATION STUDY OF INTRAVENOUSLY ADMINISTERED SB 11285 ALONE AND IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS
    Luke, Jason
    Janku, Filip
    Olszanski, Anthony
    Leach, Kevin
    Iyer, Radhakrishnan
    Abbas, Atif
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A224 - A224
  • [46] Phase 1b study of weekly split-dose selinexor in soft tissue sarcoma (STS).
    Salawu, Abdulazeez
    Gupta, Abha A.
    Al-Ezzi, Esmail Mutahar
    Genta, Sofia
    Malone, Eoghan Ruadh
    Vora, Tushar Shailesh
    Watson, Geoffrey Alan
    Vornicova, Olga
    Wang, Lisa
    Arones, Limore
    Phillips, Madeline J.
    Lee, Jasmine
    Razak, Albiruni Ryan Abdul
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide
    Sant P Chawla
    Arthur Staddon
    Andrew Hendifar
    Conrad A Messam
    Rita Patwardhan
    Yasser Yasser Mostafa Kamel
    BMC Cancer, 13
  • [48] Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide
    Chawla, Sant P.
    Staddon, Arthur
    Hendifar, Andrew
    Messam, Conrad A.
    Patwardhan, Rita
    Kamel, Yasser Mostafa
    BMC CANCER, 2013, 13
  • [49] HIGH-DOSE DTIC IN ADVANCED SOFT-TISSUE SARCOMAS IN THE ADULT - A PHASE II STUDY OF THE EORTC SOFT-TISSUE AND BONE-SARCOMA-GROUP
    BUESA, JM
    MOURIDSEN, HT
    VANOOSTEROM, AT
    VERWEIJ, J
    WAGENER, T
    STEWARD, W
    POVEDA, A
    VESTLEV, PM
    THOMAS, D
    SYLVESTER, R
    ANNALS OF ONCOLOGY, 1991, 2 (04) : 307 - 309
  • [50] Phase 1b dose escalation study of erlotinib in combination with infusional 5-fluorouracil, leucovorin, and oxaliplatin in patients with advanced solid tumors
    Hanauske, Axel-R.
    Cassidy, Jim
    Sastre, Javier
    Bolling, Claus
    Jones, Robert J.
    Rakhit, Ashok
    Fettner, Scott
    Brennscheidt, Ulrich
    Feyereislova, Andrea
    Diaz-Rubio, Eduardo
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 523 - 531
12345